GAGANDEEP DHALIWAL: Open Payments
NPI 1265407944 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,935 in 62 payments from 11 companies in 2025. Trend: 2023 $1,622 · 2024 $1,470 · 2025 $1,935
Food & beverage: $1,935
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $396 |
| Otsuka America Pharmaceutical, Inc. | 11 | $323 |
| ABBVIE INC. | 8 | $255 |
| Alkermes, Inc. | 4 | $195 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $194 |
| Vanda Pharmaceuticals Inc. | 7 | $138 |
| Collegium Pharmaceutical, Inc. | 1 | $124 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| Janssen Pharmaceuticals, Inc | 4 | $89 |
| Corium, LLC | 3 | $66 |
Products named: Auvelity, REXULTI, VRAYLAR, CAPLYTA, FANAPT, Jornay PM, INGREZZA, LYBALVI.
Industry payments across AL — which companies pay providers there.
